首页> 外文OA文献 >Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
【2h】

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells

机译:通过原代乳腺上皮细胞的致癌转化产生的人乳腺癌细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A number of genetic mutations have been identified in human breast cancers, yet the specific combinations of mutations required in concert to form breast carcinoma cells remain unknown. One approach to identifying the genetic and biochemical alterations required for this process involves the transformation of primary human mammary epithelial cells (HMECs) to carcinoma cells through the introduction of specific genes. Here we show that introduction of three genes encoding the SV40 large-T antigen, the telomerase catalytic subunit, and an H-Ras oncoprotein into primary HMECs results in cells that form tumors when transplanted subcutaneously or into the mammary glands of immunocompromised mice. The tumorigenicity of these transformed cells was dependent on the level of ras oncogene expression. Interestingly, transformation of HMECs but not two other human cell types was associated with amplifications of the c-myc oncogene, which occurred during the in vitro growth of the cells. Tumors derived from the transformed HMECs were poorly differentiated carcinomas that infiltrated through adjacent tissue. When these cells were injected subcutaneously, tumors formed in only half of the injections and with an average latency of 7.5 weeks. Mixing the epithelial tumor cells with Matrigel or primary human mammary fibroblasts substantially increased the efficiency of tumor formation and decreased the latency of tumor formation, demonstrating a significant influence of the stromal microenvironment on tumorigenicity. Thus, these observations establish an experimental system for elucidating both the genetic and cell biological requirements for the development of breast cancer.
机译:在人类乳腺癌中已经鉴定出许多遗传突变,但是共同形成乳腺癌细胞所需的突变的特定组合仍然未知。鉴定该过程所需的遗传和生化改变的一种方法涉及通过引入特定基因将原代人乳腺上皮细胞(HMEC)转化为癌细胞。在这里我们表明,将编码SV40大T抗原,端粒酶催化亚基和H-Ras癌蛋白的三个基因引入初级HMECs中会导致形成皮下或免疫功能低下的小鼠乳腺移植瘤的细胞。这些转化细胞的致瘤性取决于ras癌基因表达的水平。有趣的是,HMEC的转化而不是其他两种人类细胞类型的转化与c-myc癌基因的扩增有关,这种扩增发生在细胞的体外生长过程中。源自转化的HMEC的肿瘤是低分化癌,可通过邻近组织浸润。当这些细胞皮下注射时,肿瘤仅在注射的一半中形成,平均潜伏期为7.5周。将上皮肿瘤细胞与Matrigel或原代人乳腺成纤维细胞混合,可以显着提高肿瘤形成的效率,并减少肿瘤形成的潜伏时间,这表明基质微环境对致瘤性具有重大影响。因此,这些观察结果建立了用于阐明乳腺癌发展的遗传和细胞生物学要求的实验系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号